Antimycobacterial and antifungal activities of selected four Salvia species

Records of Natural Products

Volumn 10, Issue 5, 2016, Pages 593-603

  Tan, Nur ^a   Satana, Dilek ^a   Sen, Burcu ^a   Tan, Emir ^a   Altan, Hilal Bardakcı ^b   Demirci, Betül ^c   Uzun, Meltem ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b YEDITEPE UNIVERSITY   (Turkey)

^c ANADOLU UNIVERSITY   (Turkey)

Author keywords

Antifungal activity; Antimycobacterial activity; Essential oils; Salvia cilicica; Salvia species

Indexed keywords

ALCOHOL; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ESSENTIAL OIL; PLANT EXTRACT; SALVIA CILICICA EXTRACT; SALVIA FRUTICOSA EXTRACT; SALVIA OFFICINALIS EXTRACT; SALVIA TOMENTOSA EXTRACT; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTHRODERMA BENHAMIAE; ARTHRODERMA GYPSEUM; ARTICLE; BACTERIAL GROWTH; BROTH DILUTION; CANDIDA; CONTROLLED STUDY; DRUG IDENTIFICATION; FUNGUS GROWTH; GROWTH INHIBITION; MASS FRAGMENTOGRAPHY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PLANT ROOT; SALVIA; SALVIA CILICICA; SALVIA FRUTICOSA; SALVIA OFFICINALIS; SALVIA TOMENTOSA;

EID: 84959522943     PISSN: None     EISSN: 13076167     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. WHO, Global tuberculosis report 2014, http://www.who.int/tb/publications/global_report/en/
2. VfA, Neue Medikamente gegen die Infektionskrankheit Tuberkulose, http://www.vfa.de/de/arzneimittel-forschung/woran-wir-forschen/tuberkulose-neue-medikamente-gegen-die-infektionskrankheit.html
3. R. Mahajan (2013). Bedaquiline: First FDA-approved drug in 40 years, Int. J. App. Basic Med. Res. 3(1), 1-2.
4. J.M. Watt and M.G. Breyer-Brandwijk (1962). The Medicinal and Poisonous Plants of Southern and Eastern Africa, 2nd ed. Edinburgh, pp.525-526.
5. A. Ulubelen, G. Topçu and C. Bozok-Johansson (1997). Norditerpenoids and Diterpenoids from Salvia multicaulis with Antituberculous Activity, J. Nat. Prod. 60, 1275-1280.
6. R.H. Pires, L.B. Montanari, C.H.G. Martins, J.E. Zaia, A.M.F. Almeida, M.T. Matsumoto and M.J.S. Mendes-Giannini (2011). Anticandidal Efficacy of cinnamon oil against planktonic and biofilm cultures of Candida parapsilosis and Candida orthopsilosis, Mycopathologia 172, 453-464.
7. R. Segal, A. Kritzman, L. Cividalli, Z. Samra, M. David and P. Tiqva (1996). Treatment of Candida nail infection with terbinafine, J. Am. Acad Dermatol. 35(6), 958-61.
8. J. Correa-Royero, V. Tangarife, C. Durán, E. Stashenko and A. Mesa-Arango (2010). In vitro antifungal activity and cytotoxic effect of essential oils and extracts of medicinal and aromatic plants against Candida krusei and Aspergillus fumigatus, Braz. J. Pharmacog. 20(5), 734-741.
9. S. Bhagra, S.A. Ganju, A. Sood, R.C. Guleria and A.K. Kanga (2013). Microsporum gypseum dermatophytosis in a patient of acquired immunodeficiency syndrome: A rare case report, Indian J. Med. Microbiol. 31, 295-298.
10. M. Concha, C. Nicklas, E. Balcells, A.M. Guzmán, H.P. Poggi, E. León and F. Fich (2012). The first case of tinea faciei caused by Trichophyton mentagrophytes var. erinacei isolated in Chile, Int. J. Dermatol. 51, 283–285.
11. P.H. Davis (ed.) (1988a.) Flora of Turkey and the East Agean Islands. Vol VII. Edinburgh University Press, Edinburgh.
12. J.B. Walker and K.J. Sytsma (2007). Staminal Evolution in the Genus Salvia (Lamiaceae): Molecular Phylogenetic Evidence for Multiple Origins of the Staminal Lever, Ann. Botany. 100, 375–391.
13. T. Baytop (1999). Turkiye‟de Bitkiler Ile Tedavi. (2nd ed.). Nobel Tip Kitapevleri Ltd Sti. Istanbul, pp.143-145.
14. B. Demirci, K.H.C. Baser, B. Yildiz and Z. Bahcecioglu (2003). Composition of the essential oils of six endemic Salvia spp. From Turkey, Flavour Fragr. J. 18,116-121.
15. B. Tepe, D. Daferera, A. Sokmen, M. Sokmen and M. Polissou (2005). Antimicrobial and antioxidant activities of the essential oil and various extracts of Salvia tomentosa Miller (Lamiaceae), Food Chem. 90, 333–340.
16. S.G. Deans and E.J.M. Simpson (2000). Antioxidants from Salvia officinalis. In: Kintzios SE Sage. Harwood Academic Publishers, pp.185-192.
17. M. Sokovic, O. Tzakou, D. Pitarokili and M. Couladis (2002). Antifungal activities of selected aromatic plants growing wild in Greece, Nahrung Food 5, 317-320.
18. L. Jirovetz, K. Wlcek, G. Buchbauer, V. Gochev, T. Girova, A. Stoyanova, E. Schmidt and M. Geissler (2007). Antifungal Activities of Essential Oils of Salvia lavandulifolia, Salvia officinalis and Salvia sclarea against Various Pathogenic Candida specie, J. Essent. Oil Bear. Pl. 10(5), 430-439.
19. G. Topçu and A.C. Gören (2007). Biological Activity of Diterpenoids Isolated from Anatolian Lamiaceae Plants, Rec. Nat. Prod. 1(1), 1-16.
20. N. Tan, M. Kaloga, O.A. Radtke, A.F. Kiderlen, S. Oksuz, A. Ulubelen and H. Kolodziej (2002). Abietane diterpenoids and triterpenoic acids from Salvia cilicica and their antileishmanial activities, Phytochemistry 61, 881-884.
21. N. Tan, B. Sen, M. Bilgin and E. Tan. Antimicrobial activity of extracts from an endemic Salvia cilicica Boiss. and Kotschy, Afr. J. Microbiol. Res. 9(2), 130-134.
22. F.W. McLafferty and D.B. Stauffer (1989). The Wiley/NBS Registry of Mass Spectral Data, J Wiley and Sons New York.
23. W.A. Koenig, D. Joulain and D.H. Hochmuth (2004). Terpenoids and Related Constituents of Essential Oils. MassFinder 3. Hochmuth DH (Ed.). Convenient and Rapid Analysis of GCMS. Hamburg, Germany.
24. D. Joulain and W.A. Koenig (1998). The Atlas of Spectra Data of Sesquiterpene Hydrocarbons, EB-Verlag, Hamburg.
25. ESO 2000 (1999). The Complete Database of Essential Oils, Boelens Aroma Chemical Information Service, The Netherlands.
26. Clinical and Laboratory Standards Institute (2011). Susceptibility testing of Mycobacteria, Nocardiae, and other aerobic Actinomycetes; Approved Standard Second Edition M24-A2. Clinical and Laboratory Standards Institute, Wayne, Pennsylvania, USA.
27. D. Amsterdam (2005). Susceptibility testing of antimicrobials in liquid media. In: Lorian V (ed). Antibiotics in Laboratory Medicine. 5th ed. Philadelphia: Williams and Wilkins, pp. 61-143.
28. P. Badiee, A.R. Nasirzadeh and M. Motaffaf (2012). Comparison of Salvia officinalis L. essential oil and antifungal agents against Candida species, J. Pharm. Technoly. Drug Res. 1, 1-5.
29. Clinical and Laboratory Standards Institute (2008). Reference method for broth dilution antifungal susceptibility testing filamentous fungi; Approved Standard Second Edition M38-A2. Clinical and Laboratory Standards Institute, Wayne, Pennsylvania, USA.
30. Clinical and Laboratory Standards Institute (2008). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard- Third Edition M27-A3. Clinical and Laboratory Standards Institute, Wayne, Pennsylvania, USA.
31. Clinical and Laboratory Standards Institute (2008). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard- Third Edition M27-S3. Clinical and Laboratory Standards Institute, Wayne, Pennsylvania, USA.
32. B. Dulger and N. Hacioglu (2008). Antifungal activity of endemic Salvia tigrina in Turkey, Trop. J. Pharmaceut. Res. 7, 1051-1054.
33. B. Fernandez-Torres, F.J. Cabanes, A. Carillo-Munoz, A. Esteban, I. Inza, L. Abarca and J. Guarro (2002). Collaborative Evaluation of Optimal Antifungal Susceptibility testing Canditions for Dermatophytes, J. Clin. Microbiol. 40, 3999-4003.
34. T. Sookto, T. Srithavaj, S. Thaweboon, B. Thaweboon and B. Shrestha (2013). In vitro effects of Salvia officinalis L. essential oil on Candida albicans, Asian Pac. J. of Trop. Biomed. 3(5), 376-380.
35. E. Pinto, L.R. Salgueiro, C. Cavaleiro, A. Palmeira and M.J. Goncalves (2007). In vitro susceptibility of some species of yeasts and filamentous fungi to essential oils of Salvia officinalis, Ind. Crop Prod. 26, 135–141.
36. V. Exarchou, L. Kanetis, Z. Charalambous, S. Apers, L. Pieters, V. Gekas and V. Goulas (2015). HPLC-SPE-NMR Characterization of Major Metabolites in Salvia fruticosa Mill. Extract with Antifungal Potential: Relevance of Carnosic Acid, Carnosol, and Hispidulin, J. Agr. Food Chem. 63(2), 457-463.
37. N. Martins, L. Barros, C. Santos-Buelga, M. Henriques, S. Silva and I.C.F.R. Ferreira (2015). Evaluation of bioactive properties and phenolic compounds in different extracts prepared from Salvia officinalis L., Food Chem. 170, 378–385.
38. G. Topcu, M. Ozturk, T. Kusman, A.A.B. Demirkoz, U. Kolak and A. Ulubelen (2013). Terpenoids, essential oil composition, fatty acid profile, and biological activities of Anatolian Salvia fruticosa Mill. Turk J Chem 37, 619-632.
39. T. Askun, G. Tumen, F. Satil and M. Ates (2009). Characterization of the phenolic composition and antimicrobial activities of Turkish medicinal plants, Pharm. Biol. 47, 563-571.
40. T. Askun, K.H.C. Baser, G. Tümen and M. Kürkcüoglu (2010). Characterization of essential oils of some Salvia species and their antimycobacterlal activities, Turk. J. Biol. 34, 89-95.
41. G.P.P. Kamatou, S.F. van Vuuren, F.R. van Heerden, T. Seaman and A.M. Viljoen (2007). Antibacterial and antimycobacterial activities of South African Salvia species and isolated compounds from S. Chamelaeagnea, S. Afr. J. Bot. 73(4), 552-557.
42. Y. Hristova, V. Gochev, J. Wanner, L. Jirovetz, E. Schmidt, T. Girova and A. Kuzmanov (2013). Chemical composition and antifungal activity of essential oil of Salvia sclarea L. from Bulgaria against clinical isolates of Candida species, J. Bio. Sci. Biotech. 2(1), 39-44.
43. G. Topcu (2006). Bioactive Triterpenoids from Salvia Species, J. Nat. Prod. 69, 482-487
44. S. Pattnaik, V.R. Subramanyam, M. Bapaji and C.R. Kole (1997). Antibacterial and antifungal activity of aromatic constituents of essential oils, Microbios 89, 39-46.
45. O. Tzakou, D. Pitarokili, I.B. Chinou and C. Harvala (2001). Composition and antimicrobial activity of the essential oil of Salvia ringens, Planta Med. 67, 81-83.